Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
McKesson
Baxter
Mallinckrodt
Boehringer Ingelheim

Last Updated: December 12, 2019

DrugPatentWatch Database Preview

NYSTATIN Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Which patents cover Nystatin, and what generic alternatives are available?

Nystatin is a drug marketed by Acp Nimble, Actavis Mid Atlantic, Crown Labs Inc, Fougera Pharms, Perrigo New York, Taro, Torrent, Vintage, Lyne, Zydus Pharms, Paddock Llc, Epic Pharma Llc, Lupin, Mayne Pharma Inc, Nesher Pharms, Upsher Smith Labs, X Gen Pharms, Alpharma Us Pharms, Fougera Pharms Inc, G And W Labs Inc, Hi Tech Pharma, Lannett Co Inc, Morton Grove, Pharm Assoc, Pharmaderm, Pharmafair, Socorro, Teva, Vistapharm, Wockhardt Bio Ag, Heritage Pharms Inc, Quantum Pharmics, Sandoz, Sun Pharm Industries, Watson Labs, Fougera, Odyssey Pharms, Amneal Pharms Llc, Dr Reddys, Glenmark Pharms Ltd, Lupin Ltd, Perrigo Uk Finco, Akorn, Anda Repository, Strides Pharma, and Teligent Pharma Inc. and is included in eighty-two NDAs.

The generic ingredient in NYSTATIN is nystatin; triamcinolone acetonide. There are eight drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the nystatin; triamcinolone acetonide profile page.

Drug patent expirations by year for NYSTATIN
Drug Prices for NYSTATIN

See drug prices for NYSTATIN

Drug Sales Revenue Trends for NYSTATIN

See drug sales revenues for NYSTATIN

Recent Clinical Trials for NYSTATIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
M.D. Anderson Cancer CenterPhase 2
National Cancer Institute (NCI)Phase 2
Medical Research Institute of New ZealandPhase 3

See all NYSTATIN clinical trials

Pharmacology for NYSTATIN
Medical Subject Heading (MeSH) Categories for NYSTATIN
Synonyms for NYSTATIN
(1S,15S,16R,17R,18S,19E,21E,25E,27E,29E,31E)-33-(((2S,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-1,3,4,7,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-d
(Liposomal Nystatin)Nyotrantrade mark
1400-61-9
33-[(3-Amino-3,6-dideoxy-beta-D-mannopyranosyl)oxy]-1,3,4,7,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-Dioxabicyclo[33.3.1]nonatriaconta-19,21,25,27,29,31-hexaene-36-carboxylic acid
400A619
AB00052062_02
AC1NSKG2
AC1NWAPF
AC1O5FWI
AI3-26526
AKOS016339654
AKOS024464748
AKOS026750173
AKOS027328052
AKOS032963569
AN-51039
AV & NYS
Barstatin 100
BCBcMAP01_000244
Biofanal
BSPBio_002119
C12155
C47H75NO17
Candex Lotion
Candio-hermal
CAS-1400-61-9
Caswell No. 607B
CCG-39702
CHEBI:473992
CHEMBL229383
CHEMBL3184748
CHEMBL450895
Comycin
CS-1235
Diastatin
DSSTox_CID_20688
DSSTox_GSID_40688
DSSTox_RID_79544
EINECS 215-749-0
EPA Pesticide Chemical Code 202800
Herniocid
HMS1920D08
HMS2091L08
HMS500N05
HSDB 3138
HY-17409
IDI1_000263
ioxabicyclo[33.3.1]nonatriaconta-19,21,25,27,29,31-hexaene-36-carboxylic acid
J10033
KS-00000GUL
KS-1373
LMPK06000004
LS-187914
LS-97612
MolPort-003-938-857
MolPort-003-983-447
MolPort-023-290-481
MolPort-029-996-248
MolPort-042-663-500
MolPort-044-723-659
Moronal
Moronal (antibiotic)
Myconystatin
Mycostatin
Mycostatin 20
Mycostatin Pastilles
Mycostatin, Nilstat
Mykinac
Mykostatyna
NCGC00183039-01
NCGC00386193-01
Nilstat
Nistatin
Nistatina [INN-Spanish]
NSC 150817
NSC-757237
NSC757237
Nyamyc
Nyotran
Nystaform
Nystan
Nystatin (Fungicidin)
Nystatin [INN:BAN:JAN]
Nystatin [USP:INN:BAN:JAN]
Nystatin + Aloe Vera Extract
Nystatin A
Nystatin A1
Nystatin A1 A2 A3 complex
Nystatin A1, A2, A3 complex
Nystatin antibiotic complex
Nystatin G
Nystatin LF (liposome)
Nystatin Suspension
Nystatin Suspension, suspension, 10,000 unit/mL in DPBS, aseptically processed, BioReagent, suitable for cell culture
Nystatin, >=4,400 USP units/mg
Nystatin, >=70% (UV), mixture of A1, A2, A3
Nystatin, European Pharmacopoeia (EP) Reference Standard
Nystatin, powder, BioReagent, suitable for cell culture
Nystatin, powder, gamma-irradiated, BioXtra, suitable for cell culture
Nystatin, United States Pharmacopeia (USP) Reference Standard
Nystatin, Vetec(TM) reagent grade, >=4400 USP units/mg
Nystatine
Nystatine [INN-French]
Nystatinum
Nystatinum [INN-Latin]
Nystatyna
Nystatyna [Polish]
Nystavescent
Nystex
Nystop
O-V Statin
Pharmakon1600-01500446
s1934
SCHEMBL10073781
SCHEMBL18633553
SCHEMBL284974
SMP1_000219
SPECTRUM1500446
Spectrum5_001333
SR-05000001687
SR-05000001687-1
SR-05000001687-2
Stamycin
Terrastatin
Tox21_113542
UNII-BDF1O1C72E component VQOXZBDYSJBXMA-NQTDYLQESA-N
UNII-W1LX4T91WI
VQOXZBDYSJBXMA-VHFLTRTASA-N
W-6067
W1LX4T91WI
ZINC252438305
ZINC252517950
ZINC253387941
Zydin E

US Patents and Regulatory Information for NYSTATIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera Pharms Inc NYSTATIN AND TRIAMCINOLONE ACETONIDE nystatin; triamcinolone acetonide OINTMENT;TOPICAL 062602-001 Oct 9, 1985 AT RX No No   Start Trial   Start Trial   Start Trial
Wockhardt Bio Ag NYSTATIN nystatin SUSPENSION;ORAL 062512-001 Oct 29, 1984 AA RX No Yes   Start Trial   Start Trial   Start Trial
Morton Grove NYSTATIN nystatin SUSPENSION;ORAL 062835-001 Nov 19, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
Fougera NYSTATIN nystatin TABLET;VAGINAL 062459-001 Nov 9, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
Fougera Pharms Inc NYSTATIN AND TRIAMCINOLONE ACETONIDE nystatin; triamcinolone acetonide CREAM;TOPICAL 062599-001 Oct 8, 1985 AT RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Boehringer Ingelheim
Baxter
AstraZeneca
Merck
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.